Related Experiment Video
Updated: May 13, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Melanie D Whittington1, Joshua T Cohen1, Peter J Neumann1
1Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.
Objectives:
Compare cost-effectiveness estimates calculated using a static approach to pricing over time with an approach that accounts for price changes over time (a dynamic approach) and identify which dynamic inputs have the greatest influence on cost-effectiveness.
Methods:
A panel of economic modeling experts identified cost-effectiveness analysis model inputs that change over time, possible values for each dynamic input, and approaches for incorporating dynamic inputs into an economic model. Informed by the advisory panel, static and dynamic cost-effectiveness estimates were calculated for 4 cases: (1) a chronically administered treatment for a chronic condition, (2) a chronically administered treatment for a catastrophic condition, (3) a 1-time treatment for a chronic condition, and (4) a 1-time treatment for a catastrophic condition.
Results:
The static cost-effectiveness estimate was less favorable than the dynamic estimate for a chronically administered drug by between 82% (case 1) and 62% (case 2), and for a 1-time drug by between 34% (case 3) and 27% (case 4). For chronically administered treatments, the post-loss-of-exclusivity price had the greatest impact on cost-effectiveness. For 1-time treatments, the age of individuals at baseline and the discount rate had a greater impact on cost-effectiveness than the drug's assumed price changes.
Conclusions:
Compared with a static approach, a dynamic approach can result in substantially different cost-effectiveness estimates, especially for treatments administered over time. To incorporate dynamics, research should prioritize estimating price changes after loss of exclusivity.
More Related Videos
08:24The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
Published on: August 25, 2023
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Mechanistic Models: Compartment Models in Individual and Population Analysis